Aonong Biotech announced that due to suspected information disclosure violations, the company previously received a notice of filing a case from the China Securities Regulatory Commission on April 22, 2026, and an advance notice of administrative penalties from the Fujian Securities Regulatory Bureau on September 1, 2026. Recently, the company and related parties received the “Administrative Penalty Decision” issued by the Fujian Securities Regulatory Bureau. The Fujian Securities Regulatory Bureau has issued a formal administrative penalty decision on the above case.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.